The Effects of Bindarit in Preventing Stent Restenosis

NCT01269242 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Restenosis

Interventions

DRUG: bindarit
DRUG: bindarit
DRUG: placebo

Sponsor

Aziende Chimiche Riunite Angelini Francesco S.p.A